The role of PKCζ in NMDA-induced retinal ganglion cell death: Prevention by aspirin

Apoptosis

Volumn 11, Issue 6, 2006, Pages 983-991

  Crisanti, P ^a   Laplace, O ^a   Lecain, E ^c   Jonet, L ^a   Jeanny, J C ^a   Omri, B ^a,b,d  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Apoptosis; Aspirin; Glaucoma; Immunocytochemistry; Neuroprotection; NMDA; PKC ; Retina; TUNEL

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C ZETA; N METHYLASPARTIC ACID; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DEATH; DRUG EFFECT; ENZYME ACTIVITY; EYE INJURY; GLAUCOMA; IMMUNOCYTOCHEMISTRY; MALE; MOLECULAR MECHANICS; NERVE CELL LESION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RETINA CELL; RETINA GANGLION CELL; RETINA ISCHEMIA; ANIMAL; APOPTOSIS; DRUG ANTAGONISM; WISTAR RAT;

ANIMALS; APOPTOSIS; ASPIRIN; MALE; N-METHYLASPARTATE; PROTEIN KINASE C; RATS; RATS, WISTAR; RETINAL GANGLION CELLS;

EID: 33745044512     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-6750-2     Document Type: Article

References (51)

1. McGeer PL, McGeer EG. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 1995; 21: 195-218.
2. Levy DI, Lipton SA. Comparison of delayed administration of competitive and uncompetitive antagonists in preventing NMDA receptor-mediated neuronal death. Neurology 1990; 40: 852-855.
3. Matini P, Moroni F, Lombardi G, Faussone-Pellegrini MS, Moroni F. Ultrastructural and biochemical studies on the neuroprotective effects of excitatory amino acid antagonists in the ischemic rat retina. Exp Neurol 1997; 146: 419-434.
4. Lam TT, Abler AS, Kwong JM, Tso MO. N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vi Sci 1999; 40: 2391-2397.
5. Manabe S, Lipton SA. Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest Ophthalmol Vis Sci 2003; 44: 385-392.
6. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME. TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 1997; 115: 1031-1035.
7. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995; 36: 774-786.
8. Koponen S, Kurkinen K, Akerman KEO, Mochly-Rosen PHC, Koistinaho J. Prevention of NMDA-induced death of cortical neurons by inhibition of protein kinase C zeta. J Neurochem 2003; 86: 442-452
9. Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 1996; 274: 1383-1385.
10. De Cristobal J, Cardenas A, Lizasoain I,et al. Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke 2002; 33: 261-267.
11. Fernandez LP. Neuroprotection by aspirin in cerebrovascular pathology. Ann R Acad Nac Med (Madr.) 2002; 119: 311-320.
12. Vartiainen N, Keksas-Goldsteine V, Goldsteins G, Koistinaho J. Aspirin provides cyclin-dependent kinase 5-dependent protection against subsequent hypoxia/reoxygenation damage in culture. J Neurochem 2002; 82: 329-335.
13. Vartiainen N, Goldsteins G, Keksa-Goldsteine V, Chan PH, Koistinaho J. Aspirin inhibits p44/42 mitogen-activated protein kinase and is protective against hypoxia/reoxygenation neuronal damage. Stroke 2003; 34: 752-757.
14. Minchin RF, Illet IK, Teitel CH, Reeves PT, Kadlubar FF. Direct O-acetylation of N-hydroxy arylamines by acetylsalicylic acid to form carcinogen-DNA adducts. Carcinogenesis 1992; 13: 663-667.
15. Hirai T, Chida K. Protein kinase C zeta (PKCzeta): Activation mechanisms and cellular functions. J Biochem 2003; 133: 1-7.
16. Duran A, Diaz-Meco MT, Moscat J. Essential role of RelA Ser311 phosphorylation by zetaPKC in NF-kappaB transcriptional activation. EMBO J 2003; 22: 3910-3918.
17. Savkovic SD, Koutsouris A, Hecht G. PKC zeta participates in activation of inflammatory response induced by enteropathogenic. E Coli Am J Physiol Cell Physiol 2003; 285: 512-521.
18. Nishizuka Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995; 9: 484-496.
19. Newton AC. Regulation of the ABC kinases by phosphorylation: Protein kinase C as a paradigm. Biochem J 2003; 370: 361-371.
20. Ono Y, Fujii T, Ogita K, Kikkawa U, Igarashi K, Nishizuka Y. Protein kinase C zeta subspecies from rat brain: Its structure, expression, and properties. Proc Natl Acad Sci USA 1989; 86: 3099-3103.
21. Nakanishi H, Exton JH. Purification and characterization of the zeta isoform of protein kinase C from bovine kidney. J Biol Chem 1992; 267: 16347-16354.
22. Nakanishi H, Brewer KA, Exton JH. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1993; 268: 13-16.
23. Muller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfzenmaier L. PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995; 14: 1961-1969.
24. Wang YM, Seibenhener ML, Vanderplas ML, Wooten MW. Atypical PKC zeta is activated by ceramide, resulting in coactivation of NF-kappaB/JNK kinase and cell survival. J Neurosci Res 1999; 55: 293-302.
25. Calcerrada MC, Miguel BG, Martin L, Catalan RE, Martinez AM. Involvement of phosphatidylinositol 3-kinase in nuclear translocation of protein kinase C zeta induced by C2-ceramide in rat hepatocytes. FEBS Lett 2002; 514: 361-365.
26. Wooten MW, Zhou G, Wooten MC, Seibenhener ML. Transport of protein kinase C isoforms to the nucleus of PC12 cells by nerve growth factor: Association of atypical zeta-PKC with the nuclear matrix. J Neurosci Res 1997; 49: 393-403.
27. White WO, Seibenheiner ML, Wooten MW. Phosphorylation of tyrosine 256 facilitates nuclear import of atypical protein kinase C. J Cell Biochem 2002; 85: 42-53.
28. Neri LM, Martelli AM, Borgatti P, Colamussi ML, Marchisio M, Capitani S. Increase in nuclear phosphatidylinositol 3-kinase activity and phosphatidylinositol (3,4,5) trisphosphate synthesis precede PKC-zeta translocation to the nucleus of NGF treated PC12 cells. FASEB J 1999; 13: 2299-2310.
29. Kishimoto A, Kajikawa N, Shiota M, Nishizuka Y. Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease. J Biol Chem 1983; 258: 1156-1164.
30. Takai Y, Kishimoto A, Inoue M, Nishizuka Y. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem 1977; 252: 7603-7609.
31. Frutos S, Moscat J, Diaz-Meco MT. Cleavage of zeta PKC but not lambda/iota PKC by caspase-3 during UV-induced apoptosis. J Biol Chem 1999; 274: 10765-10770.
32. Smith L, Chen L, Reyland ME, et al. Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system. J Biol Chem 2000; 275: 40620-40627.
33. Crisanti P, Leon A, Lim DM, Omri B. Aspirin prevention of NMDA-induced neuronal death by direct protein kinase Czeta inhibition. J Neurochem 2005; 93: 1587-1593.
34. Hrabetova S, Sacktor TC. Bidirectional regulation of protein kinase M zeta in the maintenance of long-term potentiation and long-term depression. J Neurosci 1996; 16: 5324-5333.
35. Hernandez AI, Blace N, Crary JF, et al. Protein kinase M zeta synthesis from a brain mRNA encoding an independent protein kinase C zeta catalytic domain. Implications for the molecular mechanism of memory. J Biol Chem 2003; 278: 40305-40316.
36. Marshall BS, Price G, Powel CT. Rat protein kinase C zeta gene contains alternative promoters for generation of dual transcripts with 5′-end heterogeneity. DNA Cell Biol 2000; 19: 707-719.
37. Tan SL, Parker PJ. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem J 2003; 376 545-552.
38. Mikati MA, Abi-Habib RJ, El Sabban ME, et al. Hippocampal programmed cell death after status epilepticus: Evidence for NMDA-receptor and ceramide-mediated mechanisms. Epilepsia 2003; 44: 282-291.
39. Wang G, Silva J, Krishnamurthy K, Tran E, Condie BG, Bieberich E. Direct binding to ceramide activates protein kinase C zeta before the formation of a pro-apoptotic complex with PAR-4 in differentiating stem cells. J Biol Chem 2005; 280: 26415-26424.
40. Smith L, Wang Z, Smith JB. Caspase processing activates atypical protein kinase C ζ by relieving autoinhibition and destabilizes the protein. Biochem J 2003; 375: 663-671.
41. Zhou G, Seibenhener ML, Wooten MW. Nucleolin is a protein kinase C-zeta substrate. Connection between cell surface signaling and nucleus in PC12 cells. J Biol Chem 1997; 272: 31130-31137.
42. Vandenplas ML, Mamidipudi V, Lamar Seibenhener M, Wooten MW. Nerve growth factor activates kinases that phosphorylate atypical protein kinase C. Cell Signal 2002; 14: 359-363.
43. Mizukami Y, Hirata T, Yoshida K. Nuclear translocation of PKC zeta during ischemia and its inhibition by wortmannin, an inhibitor of phosphatidylinositol 3-kinase. FEBS Lett 1997; 401: 247-251.
44. Pizzi M, Goffi F, Boroni F, et al. Opposing roles for NF-kappa B/Rel factors p65 and c-Rel in the modulation of neuron survival elicited by glutamate and interleukm-1beta. J Biol Chem 2002; 277: 20717-20723.
45. Kitaoka Y, Kumai T, Kitaoka Y, et al. Nuclear factor-kappa B p65 in NMDA-mduced retinal neurotoxicity. Brain Res Mol Brain Res 2004; 131: 8-16.
46. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107: 135-142.
47. Fiorucci S, Santucci L, WallaceJ L, et al. Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc Natl Acad Sci USA 2003; 100: 10937-10941.
48. Pique M, Barragan M, Dalmaub M, Bellosillo B, Pons G, Gil J. Aspirin induces apoptosis through mitochondrial cytochrome c release. FEBS Lett 2000; 480: 193-196.
49. Lloyd FP Jr., Slivova V, Valachovicova T, Sliva DI. Aspirin inhibits highly invasive prostate cancer cells. Int J Oncol 2003; 23: 1277-1283.
50. Hewett SJ, Uliasz TF, Vidwans AS, Hewett JA. Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 2000; 293: 417-425.
51. Pillinger MH, Capodici C, Rosenthal P, et al. Modes of action of aspirin-like drugs: Salicylates inhibit Erk activation and integrin-dependent neutrophil adhesion. Proc Natl Acad Sci USA 1998; 95: 14540-14545.